Tetrabutylammonium difluorotriphenylsilicate | CAS:163931-61-1

We serve Tetrabutylammonium difluorotriphenylsilicate CAS:163931-61-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Tetrabutylammonium difluorotriphenylsilicate

Synonyms：
difluoro(triphenyl)silanuide,tetrabutylazanium
TetrabutylaMMoniuM Difluorotriphenylsilicate
 
Molecular Formula: C34H51F2NSi
Molecular weight：539.85800
 
Melting point: 157-163ºC(lit.)
 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Contact us for information like Tetrabutylammonium difluorotriphenylsilicate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TetrabutylaMMoniuM Difluorotriphenylsilicate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetrabutylammonium difluorotriphenylsilicate Use and application,Tetrabutylammonium difluorotriphenylsilicate technical grade,usp/ep/jp grade.


Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.L-Threoninamide,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysylglycylglycyl-O-(1,1-dimethylethyl)- manufacturer Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said.Peptide nucleic acid,(H-C-T-C-T-T-C)-D-Lys-D-Tyr-Lys-D-Tyr-D-Lys-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide supplier The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.5-nitro-1-(4-nitrobenzoyl)-1H-indazole vendor The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.